With diabetes and CKD projected to be the seventh and fifth leading cause of premature mortality worldwide by 2040, respectively [7], novel and effective treatment options are critical
By dampening dopamine-driven impulsivity around eating, Wegovy can help reduce cravings for sugar, refined carbohydrates, and calorie dense snacks
Research and real-world patient experiences show that GLP-1 medications do more than promote weight lossthey actively protect the heart
The results of recent work reveal that GLP-1R is expressed in neuropeptide Y (NPY)-positive neurons in the AP and that GLP-1 can directly or indirectly inhibit neuronal signaling in the anorexigenic NPY system via agonism of GLP-1R 19
Most people want to know how quickly they will see changes and what improvements are realistic
Uncertainty around prepregnancy GLP-1 benefits The use of GLP-1 RAs before pregnancy, followed by discontinuation, was associated with a mean gestational weight gain of 3.3 kg compared to unexposed women